Recital 37, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 3×

Whereas the principle whereby inventions must be excluded from patentability where their commercial exploitation offends against ordre public or morality must also be stressed in this Directive;

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    The preamble to the Directive states as follows: ‘… Whereas, in particular in the field of genetic engineering, research and development require a considerable amount of high-risk investment and therefore only adequate legal protection …

    18 Oct 2011 · 62010CJ0034

  • Opinion of Advocate General Cruz Villalón delivered on 17 July 2014. International Stem Cell Corporation v Comptroller General of Patents, DDecision

    Recitals 5, 16, 20, 21, 36 to 39, and 42 of the Directive read as follows: … differences exist in the legal protection of biotechnological inventions offered by the laws and practices of the different Member States; … such differences …

    17 Jul 2014 · 62013CC0364

  • Judgment of the Court (Grand Chamber), 18 December 2014. International Stem Cell Corporation v Comptroller General of Patents, Designs and TDecision

    Recitals 1 to 3, 16, 37 to 39, 42 and 43 in the preamble to Directive 98/44 are worded as follows: ‘(1) Whereas biotechnology and genetic engineering are playing an increasingly important role in a broad range of industries and the …

    18 Dec 2014 · 62013CJ0364